BIOCONNECT SYSTEMS INC

Profile

Company Names

BIOCONNECT SYSTEMS INC

Addresses

124 SOUTH MAPLE STREET, SUITE 220, AMBLER, PA 19002

Phone Numbers

215-646-6830

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$11,024,912.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-09-18 
$9,069,922.00 
$12,500,000.00 
$3,430,078.00 
Equity 
2
2012-11-27 
$1,485,794.00 
$1,600,000.00 
$114,206.00 
Debt 
1
2012-01-09 
$469,196.00 
$938,392.00 
$469,196.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ADAM 
D. 
DAKIN 
EXECUTIVE OFFICER, DIRECTOR
BIOCONNECT SYSTEMS INC
MICHAEL 
 
DUGERY 
EXECUTIVE OFFICER, DIRECTOR
BIOCONNECT SYSTEMS INC
CHARLES 
G. 
HADLEY 
DIRECTOR
TRANSPORT PHARMACEUTICALS INC   |  REPLICATION MEDICAL, INC   |  BIOCONNECT SYSTEMS INC
ROBERT 
 
WEISSKOFF 
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC   |  ACCURI CYTOMETERS INC   |  TRANSAVE INC   |  IKANO THERAPEUTICS INC.   |  ACORN CARDIOVASCULAR INC   |  VIEWRAY INC   |  BIOCONNECT SYSTEMS INC   |  AMPHORA MEDICAL, INC.   |  CARIBOU BIOSCIENCES, INC.   |  IOWA APPROACH, INC.   |  ZENFLOW, INC.   |  TEMPEST THERAPEUTICS, INC.   |  FARAPULSE, INC.   |  CHECKMATE PHARMACEUTICALS, INC.   |  AFFINIA THERAPEUTICS INC.   |  XILIO THERAPEUTICS, INC.   |  RARECYTE, INC.   |  SHOUTI INC.   |  BASECAMP BIO INC.   |  ADELA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-09-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-18 
2012-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-11-27 
2012-01-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-01-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#